{
    "2019-09-12": [
        [
            {
                "time": "",
                "original_text": "医药板块业绩处于真空期继续配置高性价比品种",
                "features": {
                    "keywords": [
                        "医药",
                        "板块",
                        "业绩",
                        "真空期",
                        "高性价比"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【民生医药|中期报告】从ROE看医药外包中报：景气、集聚",
                "features": {
                    "keywords": [
                        "民生医药",
                        "中期报告",
                        "ROE",
                        "医药外包",
                        "景气",
                        "集聚"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "美迪西冲刺科创板，下一个药明康德还是小而美的CRO？",
                "features": {
                    "keywords": [
                        "美迪西",
                        "科创板",
                        "药明康德",
                        "CRO"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}